Azithromycin Compared with ??-Lactam Antibiotic Treatment Failures in Pneumococcal Infections of Children
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 23 (5) , 399-405
- https://doi.org/10.1097/01.inf.0000122605.34902.49
Abstract
To determine whether treatment failures occurred more commonly with azithromycin than with beta-lactam antibiotics in children who developed invasive pneumococcal disease within 30 days of receiving prior antimicrobial therapy. Retrospective review of medical records of children evaluated at Texas Children's Hospital between 1996 and 2002 who had received antimicrobials (azithromycin or a beta-lactam antibiotic) and developed invasive pneumococcal disease within 30 days. Treatment failure was defined as invasive pneumococcal infection that occurred while taking antimicrobials or within 3 days of stopping azithromycin treatment or 1 day of stopping beta-lactam treatment. Penicillin and azithromycin susceptibilities were determined and categorized according to National Committee for Clinical Laboratory Standards guidelines. We identified 21 and 33 children with similar demographic features who had developed invasive pneumococcal disease within 1 month of receiving azithromycin or a beta-lactam antibiotic, respectively. Eleven (52%) children in the azithromycin group and 11 (33%) in the beta-lactam group met the definition for treatment failures (P = 0.34). Eight treatment failures while receiving azithromycin were caused by pneumococci with the macrolide-resistant (M) phenotype, 2 with the macrolide-, lincosamide- and streptogramin B-resistant (MLSB) phenotype and 1 by a macrolide-susceptible organism. In the beta-lactam group 7 had a penicillin-resistant isolate, 3 had an intermediately susceptible isolate and 1 had a susceptible isolate. Our study suggests that treatment failures among patients who developed invasive disease within 30 days of receiving an antimicrobial occur as frequently in patients who receive beta-lactam antibiotics as in those who receive azithromycin. Furthermore macrolide resistant organisms are not more likely to be recovered after a macrolide treatment failure than a penicillin-nonsusceptible isolate being recovered after a beta-lactam treatment failure (P = 1.0).Keywords
This publication has 25 references indexed in Scilit:
- Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 2002
- Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutationDiagnostic Microbiology and Infectious Disease, 2002
- Emergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Macrolide Resistance Among Invasive Streptococcus pneumoniae IsolatesPublished by American Medical Association (AMA) ,2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibioticsThe Pediatric Infectious Disease Journal, 2001
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with LevofloxacinClinical Infectious Diseases, 2000
- Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniaeClinical Microbiology Reviews, 1998
- Breakthrough Sepsis in Macrolide-Resistant Pneumococcal InfectionThe Pediatric Infectious Disease Journal, 1996